Hirohito Kubota

14PUBLICATIONS
89CO-AUTHORS
Molecular targetsNanotoxicology, health and safetyMedical infection agents (incl. prions)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 25, 2026
Feasibility and Efficacy of Lorlatinib in Japanese Patients With Relapsed/Refractory ALK-Aberrant Neuroblastoma.

|May 07, 2026
Successful Completion of High-Risk Neuroblastoma Therapy After Stabilization of Pulmonary Hypertension With Tadalafil.

|Apr 29, 2026
Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.

|Mar 06, 2026
BCL11B enhancer hijacking by t(14;16)(q32;q24) translocation defines a novel high-risk subtype of T-ALL.

Kaito Mimura, Akira Kaino, Yotaro Ochi

|Jan 06, 2026
Combination of oral temozolomide and etoposide as palliative chemotherapy for recurrent or progressive neuroblastoma.

Katsutsugu Umeda, Satoshi Saida, Hirokazu Kobushi

|Nov 02, 2025
Clinical Impact of Immunoglobulin Heavy Chain Clonality in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.

Yuta Katai, Tatsuya Kamitori, Satoshi Saida

Pageof 3

Frequent Collaborators

11 joint publications

Itaru Kato

11 joint publications

Katsutsugu Umeda

7 joint publications

Hidefumi Hiramatsu

7 joint publications

Junko Takita